ITC-6146RO

· IntoCell, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ITC-6146RO, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy [Phase 1]